IMPAIRED FIBRINOLYSIS AS AN ESSENTIAL CONTRIBUTION TO THROMBOSIS IN PATIENTS WITH LUPUS ANTICOAGULANT

被引：0
|
作者：
TSAKIRIS, DA [1 ]
MARBET, GA [1 ]
MAKRIS, PE [1 ]
SETTAS, L [1 ]
DUCKERT, F [1 ]
机构：
[1] ARISTOTELIAN UNIV SALONIKA,DEPT MED PROPAEDEUT A,SALONIKA,GREECE
来源：
THROMBOSIS AND HAEMOSTASIS | 1989年 / 61卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 177
页数：3
相关论文
共 50 条
  • [41] NEONATAL AORTIC THROMBOSIS ASSOCIATED WITH THE LUPUS ANTICOAGULANT
    SHERIDANPEREIRA, M
    PORRECO, RP
    HAYS, T
    BURKE, MS
    OBSTETRICS AND GYNECOLOGY, 1988, 71 (06): : 1016 - 1018
  • [42] IMPAIRED FIBRINOLYSIS IN PERITONEAL-DIALYSIS PATIENTS - ITS CONTRIBUTION TO THROMBOTIC TENDENCY
    SALOMONE, M
    CANAVESE, C
    SCAGLIA, C
    TOGNARELLI, G
    MANSIONE, A
    SEGOLONI, GP
    VERCELLONE, A
    PERITONEAL DIALYSIS BULLETIN, 1985, 5 (04): : 272 - 272
  • [43] LUPUS NEPHRITIS WITH THROMBOSIS AND ABNORMAL FIBRINOLYSIS - EFFECT OF ANCROD
    KANT, KS
    POLLAK, VE
    DOSEKUN, A
    GLASGREENWALT, P
    WEISS, MA
    GLUECK, HI
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1985, 105 (01): : 77 - 88
  • [44] PROTEIN-S AND ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH LUPUS ANTICOAGULANT WITH OR WITHOUT THROMBOSIS
    PANZER, S
    PABINGER, I
    DUDCZAK, R
    SCHULZ, E
    WURZ, E
    LECHNER, K
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 392 - 392
  • [45] Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
    Posch, Florian
    Gebhart, Johanna
    Rand, Jacob H.
    de Laat, Bas
    Koder, Silvia
    Quehenberger, Peter
    Ay, Cihan
    Pabinger, Ingrid
    BLOOD, 2015, 126 (23)
  • [46] SUPRANORMAL VON-WILLEBRAND-FACTOR MULTIMERS IN PATIENTS WITH LUPUS ANTICOAGULANT AND THROMBOSIS
    SCHINCO, P
    BORCHIELLINI, A
    MONTARULI, B
    TAMPONI, G
    PILERI, A
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 950 - 950
  • [47] ANTIPHOSPHOLIPID ANTIBODIES (APLA) IN PATIENTS PRONE TO THROMBOSIS - PREVALENCE, SPECIFICITY, AND RELATION TO IMPAIRED FIBRINOLYSIS
    KIENAST, J
    BOHM, H
    OSTERMANN, H
    VANDELOO, J
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 374 - 374
  • [48] RECURRENT THROMBOSIS AND LUPUS ANTICOAGULANT IN SYSTEMIC LUPUS-ERYTHEMATOSUS - REPLY
    GLUECK, HI
    ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (06) : 1247 - 1247
  • [49] Perindopril improves the impaired endogenous fibrinolysis in essential hypertension
    Fogari, R
    Zoppi, A
    Corradi, L
    Preti, P
    Mugellini, A
    Marasi, G
    Pasotti, C
    HYPERTENSION, 2001, 38 (04) : 981 - 981
  • [50] Acquired activated protein C resistance in patients with lupus anticoagulant and essential thrombocythemia
    Gabazza, EC
    Takeya, H
    Deguchi, H
    Taguchi, O
    Wada, H
    Nishioka, J
    Zhou, H
    Suzuki, K
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1997, 3 (02) : 119 - 123
12345